(Q36310311)

13 August 2017

1 reference

title

The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link? (English)

1 reference

13 August 2017

0 references

Chris Bushe

1

1 reference

PubMed ID

16280340

13 August 2017

Carol Paton

series ordinal

2

1 reference

PubMed ID

16280340

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Journal of Psychopharmacology

13 August 2017

1 reference

13 August 2017

19

1 reference

13 August 2017

6 Suppl

1 reference

13 August 2017

76-83

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

13 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Effects of olanzapine on lipid abnormalities in elderly psychotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Weight decline in patients switching from olanzapine to quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105058719

21 January 2018

Identifiers

DOI

10.1177/0269881105058719

1 reference

13 August 2017

1 reference

PubMed ID

16280340